Anne Kathleen Ellis

Anne Kathleen Ellis

Auto-generated profile, based on publicly available information

Anne Kathleen Ellis

Allergy Research Unit Kingston Health Sciences Centre− Kingston General Hospital Site Kingston Ontario Canada

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
AEAnne K. Ellis
Anne K. Ellis
JDJames H. Day
James H. Day

1 September 2017 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
WAWaleed Alqurashi
Waleed Alqurashi
AEAnne K. Ellis
Anne K. Ellis

1 June 2014 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
MNMichelle L. North
Michelle L. North
TTTim K. Takaro
Tim K. Takaro
MDMiriam L. Diamond
Miriam L. Diamond
AEAnne K. Ellis
Anne K. Ellis

28 July 2023 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
SLSophia Linton
Sophia Linton
LHLubnaa Hossenbaccus
Lubnaa Hossenbaccus
AEAnne K. Ellis
Anne K. Ellis

24 April 2015 in Allergy, Asthma & Clinical Immunology
Verified
Journal Article
Open access
PDF file
AEAnne K Ellis
Anne K Ellis
MSMena Soliman
Mena Soliman
LSLisa Steacy
Lisa Steacy
MBMarie-Ève Boulay
Marie-Ève Boulay
LBLouis-Philippe Boulet
Louis-Philippe Boulet
HNHelen Neighbour
Helen Neighbour
The Nasal Allergen Challenge (NAC) model allows the study of Allergic Rhinitis (AR) pathophysiology and the proof of concept of novel therapies. The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC) aims to optimize the protocol, ensuring reliability and repeatability of symptoms to better evaluate the therapies under investigation. 20 AR participants were challenged, with 4-fold increments of their respective allergens every 15 minutes, to determine the qualifying allergen concentration (QAC) at which the Total Nasal Symptom Score (TNSS) of ≥10/12 OR a Peak Nasal Inspiratory Flow (PNIF) reduction of ≥50% from baseline was achieved. At the NAC visit, the QAC was used in a single challenge and TNSS and PNIF were recorded at baseline, 15 minutes, 30 minutes, 1 hour, and hourly up to 12 hours. 10 additional ragweed allergic participants were qualified at TNSS of ≥8/12 AND ≥50% PNIF reduction; the Cumulative Allergen Challenge (CAC) of all incremental doses was used during the NAC visit. 4 non-allergic participants were challenged with the highest allergen concentration. In the QAC study, a group qualified by only meeting PNIF criteria achieved lower TNSS than those achieving either TNSS criteria or PNIIF+TNSS (p<0.01). During the NAC visit, participants in both studies reached their peak symptoms at 15minutes followed by a gradual decline, significantly different from non-allergic participants. The “PNIF only” group experienced significantly lower TNSS than the other groups during NAC visit. QAC and CAC participants did not reach the same peak TNSS during NAC that was achieved at screening. QAC participants qualifying based on TNSS or TNSS+PNIF managed to maintain PNIF scores. Participants experienced reliable symptoms of AR in both studies, using both TNSS and PNIF reduction as part of the qualifying criteria proved better for qualifying participants at screening. Phenotyping based on pattern of symptoms experienced is possible and allows the study of AR pathophysiology and can be applied in evaluation of efficacy of a novel medication. The AR-CIC aims to continue to improve the model and employ it in phase 2 and 3 clinical trials.

1 November 2000 in The Journal of the American Board of Family Medicine
Verified
Journal Article
Open access
PDF file
AEAnne K. Ellis
Anne K. Ellis
SVSarita Verma
Sarita Verma
Background: The objective of this study was to undertake an exploratory evaluation of quality-of-life indicators for women suffering from urinary tract infections. Methods: The RAND 36-Item Health Survey 1.0 (SF-36) was administered to 47 women with a diagnosed urinary tract infection who were being cared for in the Family Medicine Center, Student Health Services, or Urology Outpatient Clinic. A control population of 71 women was obtained from the female members of an undergraduate geography class, a community basketball league, and a local women9s choir. Results: All subsections of the SF-36 quality-of-life indices were significantly decreased in the subject population compared with the control population (lower score indicates lower quality of life): patient general health perception (63.3 vs 78.9, P < .001) physical functioning (76.6 vs 87.6, P = .012), role limitation owing to physical health (53.8 vs 93.0, P < .001) and emotional health (67.4 vs 88.3, P < .001), vitality (43.0 vs 64.9, P < .001), emotional well-being (64.4 vs 80.2, P < .001), pain (58.7 vs 91.5, P < .001), and social functioning (60.4 vs 90.4. P < .001). Conclusion: Suffering from an urinary tract infection has a detrimental influence on patient quality of life. The effect of urinary tract infections on women and their perception of quality of life have not been hitherto reported in the medical literature. The Significant findings in this study call into question whether acute, non-life-threatening illness should be regarded as benign.